Filter
352
Text search:
Mongolia
Featured
Recommendations
26
New Publications
61
Language
Document type
No document type
203
Studies & Reports
77
Guidelines
37
Manuals
17
Strategic & Response Plan
5
Situation Updates
4
Fact sheets
4
Training Material
2
Resource Platforms
2
Countries / Regions
Global
25
Asia
20
Bangladesh
7
South–East Asia Region
7
Western Pacific Region
7
Myanmar / Burma
5
Kenya
4
Mongolia
4
Philippines
3
India
3
Nepal
3
Afghanistan
3
Thailand
3
Russia
3
Nigeria
2
Ethiopia
2
Somalia
2
Syria
2
Cambodia
2
China
2
Mozambique
2
Brazil
2
Madagascar
2
Western and Central Europe
2
Eastern Europe
2
Sierra Leone
1
Senegal
1
Congo, Democratic Republic of
1
Uganda
1
Niger
1
Zimbabwe
1
Haiti
1
Pakistan
1
South Sudan
1
Iraq
1
Lebanon
1
Turkey
1
Rwanda
1
Indonesia
1
South Africa
1
Sudan
1
Central African Republic
1
Peru
1
Serbia
1
Ukraine
1
Ecuador
1
Yemen
1
Latin America and the Carribbean
1
Paraguay
1
Africa
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
42
Public Health
35
Clinical Guidelines
35
Women & Child Health
26
Key Resources
25
Pharmacy & Technologies
5
Capacity Building
1
Toolboxes
HIV
52
TB
36
Disability
35
Mental Health
30
COVID-19
21
Planetary Health
20
Global Health Education
16
Pharmacy
8
NTDs
8
Health Financing Toolbox
8
AMR
7
Natural Hazards
6
Rapid Response
6
NCDs
5
Polio
4
Refugee
4
Conflict
3
Caregiver
3
2.0 Rapid Response
3
Specific Hazards
2
Ebola & Marburg
1
Tuberculosis cases, TB deaths
This policy brief presents a summary of current evidence on vulnerability to TB and proposes interventions for equitable, person-centred, and human rights-based TB prevention and care. It aligns with WHO policies and guidance on TB prevention and screening, management of TB and comorbidities, access
...
National tuberculosis (TB) prevalence surveys provide a nationally representative measurement of the burden of TB disease in the population, at a given point in time. Repeat surveys allow assessment of trends and tracking of progress towards national and global targets for reductions in TB disease b
...
This guide aims to provide an overview of successful practice from the field for the disaster risk reduction/management practitioner interested in EWS. It presents guiding principles that will build a strong foundation for the design or strengthening of EWS at any level. It is not an operational, bu
...
The Training Toolkit for Community Early Warning Systems is an operational manual that aims to strengthen early warning systems in a developing country context. It accompanies and should put into practice the guiding strategic principles found in the Community Early Warning Systems: Guiding Principl
...
The health impacts of climate change are no longer a distant threat. They are being felt here and now and becoming more extreme.
To address these threats, the WHO Asia-Pacific Centre for Environment and Health in the Western Pacific Region (ACE) was established in 2019 through a partnership with
...
Global tuberculosis report 2025
recommended
The WHO Global tuberculosis report 2025 provides a comprehensive and up-to-date assessment of the TB epidemic and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
Abrupt reductions in international HIV assistance in 2025 have deepened existing funding shortfalls. The OECD estimates that external health assistance is projected to drop by 30–40% in 2025 compared with 2023, causing immediate and even more severe disruption to health services in low- and middle
...
The findings of the report are both urgent and devastating. At the current rate of progress, by 2040 we would still have 1.9 million new HIV infections and 990,000 AIDS-related deaths in children. But if funding for HIV prevention and treatment continues to fall as current trends suggest, the world
...
Progress on the sustainable development goals.
Summary of new viruses this week: Pakistan—three wild poliovirus type 1 (WPV1) cases and five WPV1-positive environmental samples; Nigeria—one circulating vaccine derived poliovirus type 2 (cVDPV2)-positive environmental sample; and, Niger—one cVDPV2 isolated from a healthy community. See coun
...